Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MYGN

Myriad Genetics

$39.41

0.55 (1.42%)

, PFE

Pfizer

$36.36

0.19 (0.53%)

07:15
06/18/18
06/18
07:15
06/18/18
07:15
Hot Stocks
Myriad Genetics BRACAnalysis CDx sPMA accepted by FDA for review »

Myriad Genetics (MYGN)…

MYGN

Myriad Genetics

$39.41

0.55 (1.42%)

PFE

Pfizer

$36.36

0.19 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Thursday
MYGN

Myriad Genetics

$38.89

-0.27 (-0.69%)

08:48
06/14/18
06/14
08:48
06/14/18
08:48
Conference/Events
Stephens to hold a field trip »

Assurex Health Site Visit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 14

    Jun

MYGN

Myriad Genetics

$38.89

-0.27 (-0.69%)

04:55
06/14/18
06/14
04:55
06/14/18
04:55
Conference/Events
Myriad Genetics management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 14

    Jun

Over a week ago
MYGN

Myriad Genetics

$38.95

-0.21 (-0.54%)

15:16
06/13/18
06/13
15:16
06/13/18
15:16
Hot Stocks
Meet Myriad: Executive VP says public 'not aware' of product portfolio depth »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 14

    Jun

MYGN

Myriad Genetics

$38.90

-0.26 (-0.66%)

14:54
06/13/18
06/13
14:54
06/13/18
14:54
Hot Stocks
Myriad's Rogers says focus should be better outcomes, not 'just' lowering costs »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 14

    Jun

MYGN

Myriad Genetics

$39.13

-0.03 (-0.08%)

14:37
06/13/18
06/13
14:37
06/13/18
14:37
Hot Stocks
Myriad's Rogers sees Prolaris becoming standard-of-care test »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 14

    Jun

MYGN

Myriad Genetics

$39.12

-0.04 (-0.10%)

13:56
06/13/18
06/13
13:56
06/13/18
13:56
Hot Stocks
Myriad executive says riskScore results 'well received' at ASCO »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 14

    Jun

MYGN

Myriad Genetics

$39.09

-0.07 (-0.18%)

13:36
06/13/18
06/13
13:36
06/13/18
13:36
Hot Stocks
Meet Myriad: Counsyl deal seen being accretive in 2020 »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 14

    Jun

MYGN

Myriad Genetics

$38.98

-0.18 (-0.46%)

13:14
06/13/18
06/13
13:14
06/13/18
13:14
Hot Stocks
Meet Myriad Genetics: A talk with EVP of Corporate Communications Ronald Rogers »

Myriad Genetics (MYGN) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 14

    Jun

MYGN

Myriad Genetics

$38.99

-0.17 (-0.43%)

13:07
06/13/18
06/13
13:07
06/13/18
13:07
Hot Stocks
Breaking Hot Stocks news story on Myriad Genetics »

Myriad Genetics sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 14

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.